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Abstract
Background: The Wnt/Wg pathway plays an important role in the developmental program of
many cells and tissues in a variety of organisms. In addition, many Wnts and components of their
downstream signaling pathways, such as β-catenin and APC, have been implicated in tumorigenesis.
Over the past years, several genes have been identified as Wnt responsive, including c-myc, siamois,
and cyclin D1.
Results: In order to identify additional genes responsive to Wnt signaling that contribute to the
transformed phenotype, we performed a cDNA subtractive hybridization screen between a mouse
mammary epithelial cell line that overexpresses Wnt-1 (C57MG/Wnt-1) and the parental cell line
(C57MG). The screen identified a total of 67 genes to be up-regulated in response to Wnt signaling.
Of these 67 genes, the up-regulation of 62 was subsequently confirmed by Northern and dot blot
analyses (and, for a subset, semi-quantitative PCR) of RNA isolated from C57MG cells subjected
to (1) an independent Wnt-1 retroviral infection, and (2) co-culture with Wnt-1 expressing cells.
Among the confirmed Wnt-1 responsive genes, we further characterized a mouse homolog of the
human transcription factor Basic Transcription Element Binding protein 2 (BTEB2), Wnt-1
Responsive Cdc42 homolog (Wrch-1), and Wnt-1 Induced Secreted Protein (WISP-1).
Conclusion: Several novel genes were identified in this screen, as well as others that have been
shown previously to be regulated by Wnt signaling, such as connexin43. The results indicate that
cDNA subtractive hybridization is a useful method for identifying genes involved in the process of
Wnt-1-induced transformation.
Background
The Wnt/Wg signal transduction pathway is an evolution-
arily conserved pathway that plays an important role in
the developmental program of many organisms (for
review see [1-4]). Genetic epistasis tests in Drosophila, in
combination with biochemical experiments performed in
Xenopus and in tissue culture cell lines, have contributed
much information to the molecular mechanisms underly-
ing Wnt signaling. In recent years, the discovery of the
genes and their protein products that are involved in Wnt
signaling has led to the development of a complex signal-
ing network that includes various scaffolding proteins,
kinases, and transcription factors. For a detailed descrip-
tion of the proteins involved, please see The Wnt Genes
Webpage [5]. With respect to the canonical Wnt/β-cat-
enin pathway, in the absence of Wnt/Wg signaling, cells
maintain low cytoplasmic levels of the oncoprotein β-cat-
enin or Armadillo (Arm), its Drosophila homolog. β-cat-
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enin is a multifunctional molecule that acts at the plasma
membrane in adherens junctions, can be found in the
cytoplasm, and is also detected in the nucleus as part of a
transcription factor complex. Upon phosphorylations at
its amino terminus by an isoform of casein kinase 1 (CK1)
and by glycogen synthase kinase-3β (GSK-3β), β-catenin
is targeted for ubiquitin-mediated degradation by the
"destruction complex" consisting of GSK-3β, the tumor
suppressor protein adenomatous polyposis coli (APC),
axin, and a member of the SCF ubiquitin ligase complex,
β-TrCP/Slimb [6,7]. In order to initiate signaling, Wnt
must bind to its receptor Frizzled and its co-receptor LRP,
leading to β-catenin stabilization. β-catenin levels now
rise in the cytoplasm, reaching a critical amount that ena-
bles β-catenin to translocate to the nucleus where it inter-
acts with Lef/TCF [8,9] and activates target gene
expression.
Besides playing a role in differentiation and development,
the Wnt/Wg signaling pathway has also been implicated
in tumorigenesis [7]. The Wnt-1 oncogene was originally
discovered as int-1, a gene whose activation upon inser-
tion of the mouse mammary tumor virus results in the for-
mation of mouse mammary tumors [10,11]. Although
Wnt-1 is not expressed in the normal mouse mammary
gland, expression of Wnt-1 in transgenic mice results in
the formation of mammary tumors. In addition, overex-
pression of Wnt-1 in mouse mammary epithelial cell lines
such as C57MG or RAC311 results in their transformation
[12]. Furthermore, in Rat1 fibroblasts, Wnt-1 overexpres-
sion induces serum-independent cellular growth in a
manner that correlates with an increase in cytoplasmic β-
catenin [13]. These results suggest that perhaps Wnt-1-
mediated transformation occurs through an increase in
cytoplasmic β-catenin levels because transformation can
take place in the absence of Wnt-1 signaling upon overex-
pression of a stable form of β-catenin. Other cell lines,
such as NIH3T3 cells, have also been employed to study
the response of endogenous β-catenin to Wnt-1 signaling
and have arrived at similar conclusions: Wnt-1 signaling
allows for accumulation of β-catenin to levels that enable
it to form a complex with Lef/TCF proteins to activate
transcription [14].
Expression of some Wnts  has been correlated with the
development of human cancer. Recently, increased
expression of Wnt-1  mRNA was observed in cell lines
derived from a human gastric cancer (OKAJIMA), pancre-
atic cancer (BxPC-3), and in 50% of primary gastric can-
cers [15]. The Wnt 2 gene is up-regulated at the mRNA
level in gastric and esophageal carcinomas as well as in
colorectal tumors at various stages [16]. Wnt-5a mRNA is
expressed at very low levels in breast cell lines and normal
breast tissue, but benign proliferations and invasive can-
cers exhibit a ten-fold and four-fold higher level of Wnt-5a
mRNA, respectively [17]. Wnt-5a is also up-regulated at
the RNA level in lung, breast, prostate carcinomas and
melanomas [18]. Wnt10B mRNA is elevated in primary
breast carcinomas and in several noncancerous and can-
cerous breast cell lines [19]. Finally, Wnt-13  mRNA is
expressed in several adult tissues and in three human can-
cer cell lines: HeLa cells (cervical cancer) and in MKN28
and MKN74 (gastric cancer), potentially implicating this
gene in tumorigenesis [20]. Thus, the up-regulation of
Wnts  is correlated with the development of multiple
tumor types, providing additional evidence that Wnt pro-
teins and the pathway(s) they regulate play an important
role in the control of cell growth and differentiation.
Mutations in several components of the Wnt signaling
pathway, such as APC and β-catenin, have also been linked
to tumorigenesis. APC is a tumor suppressor gene that is
mutated in up to 80% of human colon carcinomas [21].
Mutations of APC result in the development of a form of
inherited colon carcinoma called Familial Adenomatous
Polyposis (FAP). Individuals with FAP develop multiple
colonic polyps throughout their life, predisposing them to
colon cancer. Elevated levels of β-catenin can also contrib-
ute to tumorigenesis. High levels of β-catenin are associ-
ated with several human cancers, including colon
carcinomas, melanomas, pilomatricomas and hepatocel-
lular carcinomas, either due to a nonfunctioning APC pro-
tein or to mutations that eliminate the phosphorylation
sites within β-catenin [6,22-25].
The diverse roles of Wnts in both development and tum-
origenesis have fostered the search for Wnt responsive
genes in these processes. Wg signaling in Drosophila  is
known to transcriptionally activate the expression of
engrailed and Ultrabithorax through the Armadillo/dTCF
complex [26,27]. Besides these Drosophila  homeobox
genes, Wnt signaling through β-catenin in Xenopus results
in the transcriptional induction of two additional home-
obox genes, siamois [28] and twin [29]. Other responsive
genes of Wnt/Wg that are transcriptionally activated by β-
catenin/Lef-TCF include the oncogenes cyclin D1 [30,31],
c-myc [32], and WISP-1 [33,34]; c-jun and fra-1 [35], as
well as the Xenopus fibronectin gene [36], connexin43 [37],
matrilysin [38], BTEB2 [39], Wrch-1 [40], and membrane-
type matrix metalloproteinase-1 (MT1-MMP) [41].
The canonical Wnt signaling pathway relies upon the acti-
vation of responsive gene expression through the β-cat-
enin/Lef-TCF complex in response to the binding of Wnt
to its receptor Frizzled. Evidence exists, however, to sug-
gest that Wnts can signal through a β-catenin/Lef-TCF-
independent mechanism to activate downstream gene
expression. These "non-canonical" pathways rely on
either (1) the phosphatidylinositol (PI) pathway to acti-
vate protein kinase C (PKC) and raise levels ofBMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
Page 3 of 14
(page number not for citation purposes)
intracellular calcium (Ca2+) in order to regulate respon-
sive gene expression (the Wnt/Ca2+ pathway) [42] or (2)
Wnt signaling through Dsh and the JNK (the Wnt/PCP
pathway) [43,44]. For example, Xenopus Wnt-5a, a Wnt
that does not induce ectopic axis formation nor stabilizes
β-catenin, employs the Wnt/Ca2+  pathway to exert its
effects [45]. Thus, it is apparent that not all Wnts initiate
the transcriptional activation of their responsive genes
through the β-catenin/Lef-TCF complex, suggesting that β-
catenin stabilization is not the sole end result of all Wnt
signaling and that other pathways can be stimulated upon
binding of Wnt to the Frizzled receptor.
The current list of Wnt/Wg responsive genes contains pri-
marily those genes whose expression is activated through
the canonical pathway. In an attempt to identify addi-
tional downstream responsive genes of the Wnt signaling
pathway that are relevant to transformation and poten-
tially tumorigenesis, we performed a suppression subtrac-
tive hybridization (SSH) screen between a Wnt-1-
expressing mouse mammary epithelial cell line (C57MG/
Wnt-1) and the parental cell line (C57MG). SSH offers
many advantages when compared to conventional meth-
ods, such as differential display (DD) and representa-
tional difference analysis (RDA), employed to identify
mRNA and/or cDNA differences between two popula-
tions. Differential display is more suitable to different cell
types rather than one cell type subjected to two different
conditions, as differences in PCR amplification can make
control mRNAs appear differentially expressed between
two populations, and results are often not reproducible
upon Northern blot analysis [46]. Representational differ-
ence analysis [47] does not rely on suppression PCR to
prevent the amplification of undesirable sequences. SSH,
on the other hand, permits the rapid isolation of both rare
and abundant messages from the tester population in two
hybridization steps followed by two PCR reactions. It has
been widely used over the past five years to identify syn-
tenin and other TNF-inducible genes in endothelial cells
[48], to contrast gene expression profiles between non-
tumorigenic rat embryo fibroblasts and H-ras transformed
cells [49], to identify differences between the bacterial
genomes Escherichia coli and Salmonella typhimuriu [50],
and to generate a testis-specific cDNA library, where rare
sequences were enriched over 1000-fold in one round of
subtractive hybridization [51].
Using the technique of SSH, we previously reported the
identification and characterization of a mouse homolog
of BTEB2  [39], Wrch-1  [40], and WISP-1  [33,34]. This
report details the remaining results of the subtractive
hybridization screen; in particular, the identification of 59
additional genes confirmed to be up-regulated in
response to Wnt signaling. These results reveal the gene
expression changes that occur in a tissue culture model
system in response to Wnt signaling and may help explain
the resulting transformed phenotype.
Results
Generation of retrovirally infected C57MG cells to study 
gene expression involved in Wnt-1-induced transformation
In order to identify downstream responsive genes of the
Wnt signaling pathway, suppression subtractive hybridi-
zation was performed between a cell line stably expressing
Wnt-1 and the parental cell line that does not express Wnt-
1. C57MG cells, a mouse mammary epithelial cell line,
were chosen because they provide an appropriate in vitro
model system for Wnt-1 signaling, and it is in this type of
cell in the mouse mammary gland that aberrant activation
of  Wnt-1  results in mammary hyperplasia (see
[12,52,53]). To achieve high levels of Wnt-1 expression,
the C57MG cells were infected with a Wnt-1 retrovirus
that contains the mouse Wnt-1 cDNA driven off the viral
long terminal repeat promoter and a puromycin resist-
ance selectable marker [52]. Control infections for this
experiment included C57MG cells infected with either an
empty vector retrovirus or a Wnt-4 retrovirus. Wnt-4 is
normally expressed in the developing mouse mammary
gland and during pregnancy [54]. Although Wnt-4 has
been shown to cause Wnt-1-like hyperplasia in the mouse
mammary gland [55], Wnt-4 has never been shown to
cause transformation of C57MG cells [56,57]. These cell
lines will be referred to as C57MG/Wnt-1, C57MG/Wnt-4,
and C57MG/Vector.
Prior to performing the cDNA subtractive hybridization,
the effects of Wnt-1 on C57MG cell morphology and on
β-catenin levels were assessed. C57MG cells normally
form a monolayer that is relatively cuboidal in shape [52].
Upon expression of Wnt-1, the cells become elongated,
refractile, and tend to overgrow one another at conflu-
ence, in contrast to that seen for C57MG/Wnt-4 and
C57MG/Vector cells, which appear to be morphologically
indistinguishable from the parental C57MG cell line (see
[39,52]). Thus, our infection of C57MG cells with a Wnt-
1 retrovirus morphologically mimics that which has been
reported [11]. In addition to a morphology change, a con-
sequence of Wnt-1 overexpression in C57MG cells is the
stabilization and accumulation of cytosolic β-catenin. We
first assessed the levels of cytosolic β-catenin in the retro-
virally-infected cell lines to ensure that the Wnt-1 signal-
ing pathway was functioning as expected in the Wnt-1-
infected C57MG cells. Cytosolic β-catenin levels in the ret-
rovirally-infected cell lines, and in the parental cell line,
were determined through metabolic labeling and immu-
noprecipitation. The amount of β-catenin immunoprecip-
itated from the C57MG/Wnt-1 cells is approximately five-
fold greater than that immunoprecipitated from the other
three cell lines (data not shown; see [39]). These findingsBMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
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are in good agreement with that described by Shimizu et
al. [56].
Suppression subtractive hybridization (SSH) allows for the 
identification of genes up-regulated in response to Wnt-1 
signaling
Overview
SSH allows for a comparison between two populations of
mRNA in order to identify genes that are more highly
expressed in the cell of interest, called the "tester" popula-
tion. For our experiments, the tester population was cre-
ated by obtaining mRNA from the C57MG/Wnt-1 cell
line, and the gene expression profile in these cells was
directly compared to that of the "driver" population,
mRNA from the C57MG parental cell line. SSH allows for
an equalization of the high- and low-abundance respon-
sive sequences within the single-stranded tester popula-
tion [58]. The relative concentrations of low-, medium-,
and high-abundance responsive sequences in the differen-
tially expressed tester hybrids was approximately 27%,
35%, and 37% of the total double-stranded tester popula-
tion, respectively [58]. The fact that these values are simi-
lar demonstrates the ability of this technique to effectively
normalize different abundances of mRNAs in a given
population.
Experimental results
C57MG cells which had been stably expressing Wnt-1 for
three weeks after retroviral infection and that were ≥95%
confluent were chosen for this analysis as this type of
experiment would allow for the identification of both
direct and indirect responsive genes to Wnt-1 signaling
and would allow us to assay the mitogenic effects of Wnt-
1 on these cells, respectively. Two thousand colonies were
picked, of which 1384 had inserts that could be
sequenced. Of these, 1195 clones were grouped into 240
clusters (a cluster consists of two or more clones) based on
identity and/or at least a fifty bp overlap using the BLAST
program to find DNA and protein matches. 131 clones
out of the total 1384 templates could not be grouped into
a cluster (only one clone was obtained for these). Thus,
371 different cDNAs were obtained from 1384 templates.
Furthermore, 58 clones out of the 1384 templates had
unreadable sequences, and thus were not pursued further.
39% of the templates (145 unique cDNAs) could be
grouped into clusters consisting of sequences having
known protein matches (32%) or known protein
homologs (7%). Sixty-one percent (61%) of the templates
(226 unique cDNAs) were grouped into clusters contain-
ing sequences having an EST match to an unknown gene
(32%) or which had no database match (29%). Therefore,
almost two-thirds of the analyzed clones represent poten-
tial novel responsive genes of Wnt-1 signaling. It is possi-
ble that this high percentage of unknown clones may be
due to a bias in the EST database towards gene expression
in normal tissues in that those genes which may be pref-
erentially activated upon transformation are not included
in this database.
The screen appears to have been successful in its ability to
use the suppression PCR effect to reduce the degree of
amplification of undesirable sequences. For instance, very
few clusters consisted of ribosomal RNAs, which should
be found at comparable levels in both C57MG/Wnt-1
cells and the parental C57MG cells. Furthermore, Wnt-1,
a gene of high abundance in the tester cell line, was nor-
malized as far as its subsequent detection during the sub-
tractive screen. These results confirm the ability of the
screen to equalize low-, medium-, and high-abundance
mRNAs, and, in particular, to identify low-abundance
mRNAs as potential Wnt-1 targets. In addition, some of
the genes identified in the screen (BTEB2 [39], connexin43
[37],  WISP-1  [33,34], and Wrch-1  [40]) have recently
been shown (by our lab and others) to be veritable
responsive genes to the Wnt signaling pathway. In addi-
tion, recent microarray experiments [59,60] have identi-
fied many of the same genes that have been observed to
be up-regulated in our screen. Of the genes listed in Table
1, only the following were not identified by Willert et al.:
cdk4 binding protein, DUB1,  FIN16,  FKBP12,
histoneH3.3, thymosinβ4, tob5, HP1.BP38, GKLF, BTEB2,
proteasome.comp.C8, protesome.iota, EI24, IGF BP5, Fat-like
gene, URE B1, rhoB, actin, collagen XII, N-cadherin, Wnt-5A-
like gene, ERK3, rat GAP, glucose-regulated protein 78, protein
phosphatase inhibitor-2, protein phosphatase type I, PTPase 2,
Wrch-1, and WISP-1. The identification of genes in com-
mon among the published screens lends credence to our
screen data and suggests that SSH is a useful method by
which to identify novel responsive genes of this signaling
pathway.
Classification of putative Wnt-1 responsive genes
39% of the sequences identified had a known protein
match or a known protein homolog in the database, and
sixty-seven of these clones were chosen for further analy-
sis. Clones that tested positive in the independent assays
described below were grouped into categories based on
putative function. Many of these clones share homology
with transcription factors, implying that the putative Wnt-
1-induced gene expression profile obtained from this
screen consists not only of genes activated directly by the
β-catenin/Lef-TCF complex, but also genes activated in
response to these transcription factors. Therefore, this pro-
file contains direct response genes to Wnt-1 signaling,
transcriptionally activated in a β-catenin-dependent and -
independent manner, as well as secondary response genes
which are activated after the immediate response genes.
Some of the putative transcription factors that are respon-
sive to Wnt-1 signaling include clones having homology
to elf-1 (an Ets-family transcription factor), E2F1, HMG14BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
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Table 1: Wnt-1 induced gene database. This table summarizes the list of putative Wnt-1 responsive clones identified in the screen, 
including accession numbers of genes to which the sequences have homology, as well as the results obtained for each clone by Northern 
blot and dot blot analyses (in some cases for the latter, results from two experiments are indicated in the "Results – dot blot" column 
and are separated by a comma). Signals were quantified using a PhosphorImager. The value in the "Results" column for "Northern Blot" 
is the measure of the ratio of the signal for each gene in the Wnt-1 cells (normalized to GAPDH) to the signal for each gene in the 
control cells (normalized to GAPDH). The table also indicates whether the gene has been confirmed by semi-quantitative RT-PCR 
analysis as a true Wnt-1 responsive gene. A description of the function of each gene is listed in the last column of the table. "nd" means 
that no signal was detected. "inc" means increase in gene expression in the Wnt-1-treated sample, with no detectable signal in the 
control.
Results
Clone Having 
Homology to:
Accession Number RT/PCR Dot Blot Northern Blot Descriptors
Activin AF41202 + 3.7, inc. 3.2 Mesderm determination factor
Cul-2 U83410 + both inc. 2.6 Cell cycle exit (cullin)
DUB1 NM 007887 + both inc. 2.2 Ubiquitin C terminal hydrolase
FAF1 U39643 + inc., 1.9 2.4 Fas-associated factor (apoptosis)
FIN16 U42385 ND 4.5, inc. 2 NTP binding protein related, FGF4 inducible
FKBP12 BC043920 + 59.9, inc. nd FK506 binding protein (cytoplasmic)
GKLF AF117109 ND 3.8, inc. 4.2 Kruppel-like trxn factor (gut)
Histone H3.3 X13605 + 23.5, inc. 7 In quiescent, differentiated cells
Thymosin β4 U38967 + 5.9, inc. 8 Sequesters actin monomers
Tob5 D38305 + 6.8, inc. 8 p185erbB2, no proliferation
Cyclin G AB005559 + both inc. 2.7 p53 target gene, inc in G1/S
EI24 U41751 + both inc. 1.3 Ectoposide-induced RNA 2.4 kb
IGF BP5 L12447 + 7.3, inc. 1.2 Myoblast differentiation-binds IGF
RNA Helicase L25126 ND 4, inc. 5.2 8 proteins, unwind dsRNA
SCID Comp. C8 D78188 ND 0.94 nd Complementing gene 2
Thrombospondin M87276 + 1.4 nd Angioenesis inhibitor
URE B1 BC054373 + both inc. nd Y phosphorylated nuclear protein; inhibits p53
Calcineurin M81475 + inc., 4.0 4.6 protein phosphatase (S/T)
Caldesmon U18419 + 8 1.8 Ca/CaM, actin binding protein of muscle
Calmodulin M19381 ND both inc. 3.2 Ca binding protein, signaling
Calponin BC061809 ND both inc. 2.7 Binds F-actin, CaM, tropomycin
Ribosomal Protein L19 BC020315 ND 0.68 3.3 Breast cancer overexpression (erbB-2)
BTEB2 AB030824 + both inc. 8.8 GC-box binding protein, trxn factor
E2F1 L21973 ND 1.4 nd Trxn factor for S phase, Rb binding protein
Elf1 AF016040 + 3.8, inc. 1.5 Ets-like factor, trxn factor
HMG14 M94283 ND 2.4 nd Chromatin factor for trxn
HP1.BP38 X19643 ND 50.8, inc. nd TIF1 binding protein, trxn
NonO BC005465 ND 1.8 nd NonPOU, octamer binding protein
Tlm X53493 ND 1.4 nd Mouse oncogene, RT homolog
Annexin VII L13129 ND both inc. nd GTP binding protein, vesicle fusion
ARF4 D87901 ND 2.6 4.4 GTPase, recruits coat proteins
Human GAP M23612 ND 0.76 nd GTPase activating protein
Rat GAP L13151 ND 1.8 nd GTPase activating protein
GDP Dissoc. Inhib. 2 NM 021494 ND inc., 11.5 1.6 Rab6 binding protein
GDP Dissoc. Inhib. 2 NM 021494 ND inc., 11.5 1.6 Rab6 binding protein
Rab11b BC066656 ND 4.6 1.7 YPT/Rab, vesicle transport
Rab14 NM 053589 ND 16.4, inc. nd LMW GTP binding protein
Rap1B U07795 ND 3.2, inc. nd Small GTP binding protein, like Ras
RhoB M74295 ND both inc. 1.3 Small GTP binding protein, actin filament functions
Actin-like protein D12816 ND 0.35 1.9 ECM/Cytoskeletal genes
Gamma/Beta actin M12481 ND 0.85 7.4 Cytoskeleton architecture
Basigin BC010270 ND 0.85 1.8 Ig glycoprotein, associated w/integrins
Collagen alpha1 (VIII) AB009993 ND 2.7, inc. 2.6 Minor ECM, inc in breast carcinomas
Collagen (XII) U25652 ND both inc. 8.8 Collagen associated protein
Connexin 43 M61896 + both inc. 24.6 Gap junction protein
Destrin BC009477 ND 2.2 2.8 Cofilin isoproein, regulates actin
Fibronectin Receptor BC059829 ND 3.6 nd a6b1 integrin
N-cadherin M31131 + 1.8 nd Cell adhesion, neural
Radixin X60672 ND 6.2, inc. 11.7 Links actin to plasma membrane, ERM
SPARC BC004638 + 1.7 2.4 ECM breakdown, secreted glycoproteinBMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
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(a protein that specifically binds the nucleosome), and to
a mouse homolog of human BTEB2 (a member of the Sp1
family of transcription factors). Other gene categories
include differentiation, calcium-related, proteolysis-
related, p53-related, GTP binding proteins, and an "other"
grouping for those clones that could not be classified in
the above categories.
Taken together, these results provide an array of potential
candidate genes involved in the transformation of
C57MG cells in response to Wnt signaling. Recently, other
groups have identified responsive genes to Wnt signaling
through the use of cDNA microarrays in various systems
[60,61]. Not surprisingly, the gene profile identified in
these systems is not entirely identical to that obtained
from our research, as each experimental setup differs
slightly in both the conditions under which the observa-
tions were made, as well the method by which the differ-
ential gene expression was assessed. Nonetheless, this
research has helped elucidate the molecular components
of Wnt signaling responsible for a given phenotype.
Independent retroviral infection and Northern blot 
analysis to confirm Wnt-1 responsive genes
In order to confirm the results of the screen, C57MG cells
were infected with a Wnt-1 or empty vector retrovirus and
passaged in tissue culture for three weeks to mimic the
conditions under which the original screen was per-
formed. After this time period and when cells were
approximately 95% confluent, RNA was isolated from the
Wnt-1-infected cells (C57MG/Wnt-1) and empty vector-
infected cells (C57MG/Vector), and Northern blot analy-
sis was done using probes prepared from the sequences.
Results from several of these Northern blots are shown in
Figure 1. The Northern blots show that the screen yielded
many genes that are up-regulated to varying levels.
Connexin43 showed greater than twenty-fold induction in
response to Wnt-1 signaling, and the remaining clones
were induced less than ten-fold. Thymosinβ4, cyclin G, cal-
desmon, BTEB2, protein phosphatase V, and histone H3.3 are
found at higher levels in the C57MG/Wnt-1 cell lines
compared to the C57MG/Vector control. FKBP12 showed
very little change in mRNA expression levels between the
two cell lines. This result suggests that SSH can identify
subtle differences in transcript levels between two cells
lines. Therefore, we have identified a group of genes
which are up-regulated in the presence of Wnt-1 signaling
three weeks after Wnt-1 retroviral infection. These genes
may or may not be direct responsive genes of Wnt-1 sign-
aling, as many of these genes may be activated as a sec-
ondary cascade of gene expression in response to Wnt-1.
The fold induction of the candidate genes is listed in Table
1, a Wnt-1-induced gene database that summarizes the
Syndecan-2 BC047144 ND inc., 1.7 3 Heparan sulfate glycoprotein, near myc on 
chromosome
Vinculin BC039174 ND 2.2 2 FA/ZA junctions, related to a-catenin
ERK3 M64301 + 3.7, inc. 1.3 S/T kinase, Y phosphorylated (by insulin/NGF)
BiP BC020235 ND 0.8 1.4 Binds Wnt-1 in ER
Nucleoporin U63839 + both inc. nd p58, nuclear protein transport
Prot. Phos'tase V X77237 ND 2 7.6 S/T, tetratricopeptide repeats
Prot. Phos'tase Inhib.-2 L20858 + 82.8, inc. nd Regulated type I phosphatase
Prot. Phos'tase I (Dis2m2) M27073 ND inc., 2.7 2.7 Yeast chromosomal disjoining
PTPase 2 S52655 ND both inc. nd Protein Y Phosphatase, T cells
Tra1 D78355 ND inc., 1.8 1.8 Ca binding protein, cell surface glycoprotein
Thymopoietin U39078 ND 1.3, inc. 2.4 Nuclear protein, LAP2 sequence similarity
Proteasome.Comp.C8 D90258 ND 5.5 nd Subunit of human proteasome
Proteasome.IOTA D10755 ND 0.85 2.4 Subunit of human proteasome
Wrch-1 AF378088 + 3.2 4.8 Cdc42 homolog
Wnt-5A-like gene M89798 + 4.8 8.4 Wnt-5A homolog
cdk4-like binding protein L01640 + 2 2.5 cdk4 binding protein
Fat-like gene AJ250768 + 5.8 1.7 Fat gene
WISP-1 AF100777 + 58.6 3.7 cyr61/CCN family
Table 1: Wnt-1 induced gene database. This table summarizes the list of putative Wnt-1 responsive clones identified in the screen, 
including accession numbers of genes to which the sequences have homology, as well as the results obtained for each clone by Northern 
blot and dot blot analyses (in some cases for the latter, results from two experiments are indicated in the "Results – dot blot" column 
and are separated by a comma). Signals were quantified using a PhosphorImager. The value in the "Results" column for "Northern Blot" 
is the measure of the ratio of the signal for each gene in the Wnt-1 cells (normalized to GAPDH) to the signal for each gene in the 
control cells (normalized to GAPDH). The table also indicates whether the gene has been confirmed by semi-quantitative RT-PCR 
analysis as a true Wnt-1 responsive gene. A description of the function of each gene is listed in the last column of the table. "nd" means 
that no signal was detected. "inc" means increase in gene expression in the Wnt-1-treated sample, with no detectable signal in the 
control. (Continued)BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
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results of the Northern blot, differential screening, and
semi-quantitative PCR experiments, along with a brief
description of each gene and the accession number to
which each clone has homology. For each experiment, the
number reported is the normalized ratio of the signal
found in the C57MG/Wnt-1 cells to the signal found in
the C57MG/Vector cells (signals were normalized to
GAPDH prior to taking the ratio). Of the 67 putative Wnt-
1 induced clones examined by Northern blot analysis,
approximately 93% (62) are induced 1.5-fold or greater in
the presence of Wnt-1 signaling. The remaining 7% of the
clones were induced less than 1.5-fold or were not
detected in the assays used to confirm up-regulation.
Semi-quantitative RT-PCR (QRT-PCR) to confirm Wnt-1 
responsive genes
Several of the clones confirmed by Northern blot analysis
were also found to be up-regulated in the C57MG/Wnt-1
cells by semi-quantitative RT-PCR (QRT-PCR) analysis
performed on the same RNA prepared for use in the pre-
viously described Northern blot experiments. A list of
these genes is found in Table 1, and Figure 2 shows typical
Northern blot analysis of putative Wnt-1 responsive genes after retroviral infection of C57MG cells Figure 1
Northern blot analysis of putative Wnt-1 responsive genes after retroviral infection of C57MG cells. C57MG 
cells were independently infected with either a Wnt-1 or empty vector retrovirus. Forty-eight hours post-infection, cells were 
split into media containing 2.5 µg/ml puromycin. Infected cells were passaged in the presence of puromycin for three weeks 
after which time total RNA was isolated from each cell line when cells were approximately 95% confluent. Northern blot anal-
ysis was performed using five µg of total RNA, and probes were prepared from the sequences obtained. Blots were subse-
quently probed for GAPDH. Signals were quantitated using the PhosphorImager.
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QRT-PCR results for four genes: an unknown gene (483),
Wrch-1, BTEB2, and IGF-BP5. In this experiment, different
amounts of RNA were subjected to QRT-PCR using the
TaqMan method (Applied Biosystems). Each gene ana-
lyzed shows a higher expression level in the C57MG/Wnt-
1 cell line than in the parental C57MG cell line. Wrch-1
and IGF-BP5 show striking patterns of expression in that
they are barely detectable in the C57MG cell line. BTEB2
and the unknown gene 483 are also expressed at higher
levels in the C57MG/Wnt-1 cell line, although expression
of each gene can be detected to some extent in the parental
cell line. In general, the QRT-PCR data are in good agree-
ment with the results obtained by Northern blot analysis,
and overall the QRT-PCR technique offers a more sensi-
tive and quantitative approach to assess changes in gene
expression levels. In some cases good probes for Northern
blot analysis could not be prepared and/or little change
was observed in transcript levels between the cell lines;
however, the ability to perform QRT-PCR for these candi-
dates enabled us to determine if these genes were respon-
sive to Wnt signaling (for example, thrombospondin and
FKBP12, respectively).
Semi-quantitative RT-PCR (QRT-PCR) confirmation of putative Wnt-1 responsive genes after retroviral infection of C57MG  cells Figure 2
Semi-quantitative RT-PCR (QRT-PCR) confirmation of putative Wnt-1 responsive genes after retroviral infec-
tion of C57MG cells. C57MG cells were infected with either a Wnt-1 or empty vector retrovirus. Forty-eight hours post-
infection, cells were split into media containing 2.5 µg/ml puromycin. Infected cells were passaged in the presence of puromycin 
for three weeks after which time total RNA was isolated from each cell line. Reverse transcription was performed on the indi-
cated amounts of total RNA, followed by PCR using primers designed for each sequence of interest and TaqMan probes 
(Applied Biosystems). triose phosphate isomerase (tpi) was used as a control in each QRT-PCR experiment.
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Co-culture assay to confirm candidate Wnt-1 responsive 
genes
Several of the Wnt-1 responsive genes that had been con-
firmed by independent retroviral infection of C57MG
cells were subsequently tested in a co-culture assay to
determine their time course of expression in response to
Wnt-1 signaling (see [62] for culture details). Co-culture
assays were carried out for various times in which C57MG
cells were plated together with QT6 or QT6 cells express-
ing Wnt-1 (QT6Wnt-1), and Northern blot analysis was
performed using total RNA isolated from the co-cultures
and probes for the genes of interest (see Table 2). A series
of random clones that showed good induction by retrovi-
ral infection, as well as several of the transcription factor
clones, were chosen for analysis. The transcription factor
genes were chosen for analysis in the co-culture assay
because it was hypothesized that they would be immedi-
ately activated in response to the Wnt-1 signal, given the
ability of other signaling pathways, such as the mitogen-
activated protein kinase (MAPK) pathway, to first activate
the transcription of genes encoding transcription factors.
This initial wave of gene expression could then contribute
to the transcriptional activation of other genes in the
pathway.
The results of the co-culture assay were striking, particu-
larly because several of the genes which were up-regulated
in response to Wnt-1 signaling in the retroviral infection
assay were not up-regulated early in the co-culture assay
(over a forty-eight hour time period). For example,
connexin43, a known responsive gene of Wnt-1 signaling
[37,63], was strongly induced in C57MG cells infected
with the Wnt-1 retrovirus after three weeks in culture, but
only modestly induced (approximately two-fold) after
forty-eight hours of co-culture. Other Wnt-1 responsive
genes identified by retroviral infection were only slightly
up-regulated in the co-culture assay, such as protein phos-
phatase V,  SPARC, and thrombospondin. One responsive
gene, thymosinβ4, was induced eight-fold in the retroviral
infection assay but was not induced in a co-culture assay
carried out from six to forty-eight hours. Furthermore, two
clones, collagen XII and BTEB2, were up-regulated two to
three hours after co-culture and in the retroviral infection
assay. Finally, of the three transcription factor clones (all
of which were induced in the retroviral infection assay),
only one (BTEB2) demonstrated transcriptional activa-
tion throughout the co-culture assay. This discrepancy in
gene expression levels probably reflects the temporal dif-
ference in the retroviral infection versus co-culture assay,
and may also be due to other factors produced by the Wnt-
1-expressing cells.
Differential screening for Wnt-1 and β-catenin responsive 
genes
Retroviral infection
Differential screening (dot blotting) was performed on
retrovirally infected C57MG cells in order to provide an
independent method for confirming the results of the
screen. Wnt-1 and empty vector retroviral infections were
carried out in C57MG cells for three weeks, and labeled
Table 2: Summary of co-culture time course data. C57MG cells were co-cultured with QT6 or QT6Wnt-1 cells for the indicated times. 
Total RNA was isolated from each co-culture, and Northern blot analysis was performed using probes to the selected genes. Signals 
were quantified using a PhosphorImager. The reported value (fold induction) is the measure of the ratio of the signal for each gene in 
the Wnt-1 co-culture (normalized to GAPDH) to the signal for each gene in the control co-culture (normalized to GAPDH), averaged 
from three independent experiments. Zero (0) indicates that no detectable difference in gene expression was observed between the 
Wnt-1 and control co-cultures. "inc." signifies an increase in gene expression in the Wnt-1 co-culture, with no detectable signal in the 
control co-culture. Negative values indicate a decrease in expression.
Time (hours) Time (days)
Gene 2 3 6 12 24 48 3 7
Connexin43 1.5 1.4 1.9 2.3
Protein phosphatase V 2 1.2 1.6 1
SPARC 1.5 1.2 1.3 2.9 -2 -1.5
Radixin 1.5 1.5 1.3 1.6
Elf-1 1.5 1.3 1.9 1.4
T h y m o s i n  b 4 1 . 20 01 . 1
WISP-1 0 1.1 2 1.5
WISP-2 1.2 1.7 3 -1.4
Collagen XII inc. inc. 2.2 inc. -4
HP1BP38 3.9 1.3 -4.6 -1.2
Myc 1.9 1.8 -3.6 0
Thrombospondin 1.5 0 2.3 1.7 1.4 1 -7 1.3
Cyclin G inc. 0 1.4 1.4 1.3 1.2 -1.5 -1.6
GKLF 1.6 1.4 1.2 1.1 1.4 1.5
BTEB2 3.6 5.7 8.3 8 11 35 4.5 2.1BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
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cDNA was prepared from each cell type and hybridized to
the prepared membranes. Table 1 includes the results of
the dot blot assay that are reported as fold activation.
Overall the results are in good agreement with those
obtained for the Northern blots performed after the retro-
viral infection of C57MG cells. In general, those genes up-
regulated by retroviral infection (as determined by North-
ern blot analysis) are also up-regulated (albeit not always
to the same level) in the differential screening assay. Some
discrepancies do exist in the data, however, with some
genes found to be more highly up-regulated by Northern
blot analysis as opposed to the levels detected in the dif-
ferential screening experiment. This might be due to the
spotting method of each clone onto the nitrocellulose
membrane, giving rise to an uneven representation.
Up-regulation of genes in response to Wnt and β-catenin signaling
Differential screening was used to identify which putative
Wnt-1 responsive genes were also up-regulated in the
presence of high levels of β-catenin. A stable C57MG cell
line was generated that overexpresses a stable form of β-
catenin having two mutations which convert threonine 41
and serine 45 to alanine residues [34]. We have chosen to
use these β-catenin cells because they consistently main-
tain high levels of stabilized β-catenin expression. This
would enable us to compare and contrast the gene expres-
sion in response to Wnt signaling through a co-culture
assay to that obtained in response to the expression of
high levels of β-catenin only.
Differential screening was performed using cDNA isolated
from the β-catenin stable cell line and from a QT6Wnt-
1+C57MG cell twelve hour co-culture. The following
genes were tested in this assay: BTEB2, nucleoporin, Wrch-
1, GKLF, tra1, elf-1, HP1.BP38, tlm, cul-2, activin, FIN16,
tob5, calponin, calmodulin, IGF BP5, EI24, thrombospondin,
proteasome component C8, fibronectin receptor, GDP dissocia-
tion inhibitor, rab11b, Wnt-5A, WISP-1, WISP-2, WISP-3,
thymosinβ4, and connexin43. In this assay, Wnt-1 signaling
was demonstrated to up-regulate BTEB2, nucleoporin, and
Wrch-1 only, while GKLF and tra1 are only up-regulated in
the presence of high levels of β-catenin. Table 3 shows
that, of the genes tested, the majority are up-regulated in
both the Wnt-1 co-culture and the stable β-catenin cell
line. Included in this category are two known Wnt-1 and
β-catenin responsive genes, connexin43 [37] and WISP-1
[33,34].
Discussion
cDNA subtractive hybridization has identified several
putative Wnt-1 responsive genes at the mRNA level in a
mammary epithelial cell line that overexpresses Wnt-1
(C57MG/Wnt-1). The up-regulation of these candidate
genes was confirmed by Northern blot analysis and differ-
ential screening of material isolated from three independ-
ent sources: 1) C57MG cells infected in an independent
retrovirus infection assay, 2) co-culture of C57MG cells
with a cell line that overexpresses Wnt-1 (QT6Wnt-1), and
3) C57MG cells that overexpress a stable form of β-cat-
enin. In addition, some of these putative Wnt-1 respon-
sive genes were confirmed by semi-quantitative RT-PCR
analysis using RNA obtained from C57MG/Wnt-1 cells
and the parental C57MG cells. Independent retroviral
infection of C57MG cells with a Wnt-1 or empty retroviral
vector confirmed that, of the 67 genes subjected to North-
ern blot analysis, QRT-PCR and/or differential screening,
approximately 93% (62) were up-regulated ≥1.5-fold by
Wnt-1 signaling.
Signaling pathways give rise to a cascade of gene expres-
sion, with the immediate response genes being activated
first, usually in the absence of any new protein synthesis
[64-66]. The function of such immediate response genes
ranges from regulators of the cell cycle to acting as tran-
scription factors [67,68]. The initial activation of tran-
Table 3: Identification of Wnt-1 and β-catenin responsive genes in 
a twelve hour co-culture assay and a stable cell line 
overexpressing the non-degradable β-catenin mutant 4145β-
catenin. Differential screening was performed using labeled 
cDNA isolated from a twelve hour Wnt-1 co-culture and a stably 
transfected C57MG cell line that overexpresses the stable β-
catenin mutant 4145β-catenin. The labeled cDNA was hybridized 
overnight with membranes spotted with the putative Wnt-1 
responsive sequences. Signals were quantified using the 
PhosphorImager, and the genes were classified based on their 
response to Wnt-1 signaling and high levels of β-catenin.
Genes Induced by Both Wnt-1 and b-catenin
Elf-1
HP1BP38
tlm
cul-2
activin
FIN-16
Tob5
Calponin
Calmodulin
IGFBP5
EI24
Thrombospondin
Proteasome component C8
Fibronectin receptor
GDP dissociation inhibitor
rab11b
Wnt-5A
WISP-1
WISP-2
WISP-3
Thymosin b4
Connexin43BMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
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scription factors then permits the activation of a second
wave of gene expression, the early or middle response
genes [64,69]. The late response genes are activated last,
and may or may not be transcriptionally regulated by the
early response genes [70,71]. In the case of Wnt-1 trans-
formation of C57MG cells, we hypothesized that these
late response genes may function to maintain the trans-
formed state of these cells throughout their lifetime in tis-
sue culture. Therefore, the screen was performed using
C57MG cells that had been stably expressing Wnt-1 for
approximately three weeks to ensure the identification of
all three categories of response genes. In addition, total
RNA was extracted when cells were approximately 95%
confluent to ensure the effects of Wnt-1-induced transfor-
mation and to enable us to determine how gene expres-
sion is regulated in response to the mitogenic effects of
Wnt signaling. It is evident to us, however, that by using
this time point of three weeks, we may potentially miss
identifying some immediate (and perhaps early) response
genes that are only transiently activated in response to
Wnt signaling, as such genes may not remain induced
over such an extended period of time. In addition, as is
true of all non-saturation screens, some known targets of
Wnt signaling were not identified, such as cyclin D1. We
recognize that this is a limitation of the screen methodol-
ogy but are still encouraged by the number of Wnt respon-
sive genes that we have identified.
The sequences having database homology and that were
confirmed to be up-regulated in response to Wnt signaling
in one (or more) of the independent assays could be cate-
gorized based upon their putative function as follows: cell
cycle exit/differentiation, transcription factors, calcium-
related, ECM/cytoskeleton, p53-related, GTP-binding pro-
teins, ubiquitin-related, and other. One category of inter-
est was that of the transcription factors, as these might
include 1) genes activated, along with β-catenin, to medi-
ate responsive gene expression and/or 2) novel β-catenin
responsive genes. We believe that the identification of a
battery of transcription factors up-regulated in response to
Wnt signaling may aid us in developing a model in which
the activation of these transcription factors, along with the
β-catenin/Lef-TCF complex, mediates the up-regulation of
other genes by Wnt signaling, including those identified
in our screen. Another category of interest consisted of
several genes involved in remodeling the extracellular
matrix (ECM) and the cytoskeleton. The identification of
these genes as potential Wnt-1 responsive genes is inter-
esting in light of the ability of Wnt-1 to radically alter the
morphology of C57MG cells, a process that involves
changing the cytoskeleton of these cells and their sur-
rounding ECM. Finally, connexin43  was identified as a
putative responsive gene of Wnt-1 signaling in our assay.
The identification of this gene as a responsive gene of the
Wnt-1 signaling pathway is expected given previous evi-
dence that it is a veritable Wnt-1 target [63] and lends cre-
dence to the ability of the screen to identify true
responsive genes of the Wnt-1 signaling pathway.
Several of the genes confirmed by independent retroviral
infection of C57MG cells, along with the putative
transcription factors, were chosen for analysis in the co-
culture assay. The co-culture assay was performed in two
phases, an early co-culture of one to four hours, and a later
co-culture of six to forty-eight hours. Several of the Wnt-1
responsive genes highly up-regulated by retroviral infec-
tion were not induced in the co-culture assay. At first this
result seemed surprising, but it can probably be explained
by the conditions under which these genes were
identified: the screen, as well as the independent retroviral
infection, was performed on cells that had been passaged
in tissue culture for three weeks after Wnt-1 retroviral
infection.
Concomitant with the co-culture assay, differential
screening was employed in order to confirm the screen
results. Many of the genes confirmed by independent ret-
roviral infection through Northern blot analysis were also
found to be induced in the differential screening assay
using C57MG cells infected with a Wnt-1 retrovirus as the
starting material. Although the fold induction was not
identical for both assays, this is to be expected given that
the methodology for each is different. Furthermore,
differential screening relies upon the ability of RNA to be
converted to labeled cDNA and for each gene to be
equally represented, in excess, on the nitrocellulose mem-
brane, in order to hybridize with the labeled cDNA. Given
these caveats, it is not surprising to see differences
between the fold activation for each gene as determined
by Northern blot analysis and differential screening. The
conversion of RNA to labeled cDNA assumes that all tran-
scripts will be converted and labeled with the same effi-
ciency by the reverse transcriptase enzyme. It is highly
possible that some transcripts will be more difficult to
convert to cDNA given the nature of their sequence. This
would give rise to an unequal representation of particular
transcripts within the cDNA mixture and could explain
the differences observed in fold activation by the differen-
tial screening method. These inherent limitations to the
differential screening technique must be taken into
account and hence the results should be confirmed by
Northern blot analysis and/or QRT-PCR to determine if in
fact the gene is regulated by Wnt-1 signaling.
The differential screening assay was also performed with a
C57MG cell line that stably overexpresses a non-degrada-
ble β-catenin mutant, and the results were compared to
those found for a differential screening assay conducted
with a twelve hour QT6Wnt-1+ C57MG co-culture. Sev-
eral of the genes transcriptionally up-regulated by theBMC Developmental Biology 2004, 4 http://www.biomedcentral.com/1471-213X/4/6
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Wnt-1 co-culture were also found to be up-regulated by
overexpressing β-catenin. This is to be expected, given that
the canonical Wnt-1 signaling pathway relies upon the β-
catenin/Lef-TCF transcription factor complex to mediate
the activation of downstream responsive genes.
Conclusions
These results provide us with a molecular signature of the
changes that occur in a mammary epithelial cell line
(C57MG) upon transformation by Wnt-1. Although it is
not possible to distinguish between genes induced
directly and indirectly by Wnt signaling using the meth-
ods described herein (because we looked three weeks after
retroviral infection and also did not analyze the promot-
ers of the identified genes for putative TCF binding sites),
the techniques utilized here still have provided us with a
useful tool to rapidly assess changes induced during the
transformation phenotype. With these results in hand, we
now have a snapshot of the gene expression changes that
take place after three weeks of Wnt-1 overexpression, and
we can use this information to understand how the pro-
tein products of these up-regulated genes help establish
and/or maintain the transformation phenotype. We sur-
mise that many changes take place in the cell upon recep-
tion of Wnt, including, on a molecular level, the
activation of various downstream signaling pathways
mediated by other transcription factors, calcium, phos-
phatases, and GTP binding proteins. These in turn go on
to activate other genes that lead to the morphological
changes apparent upon transformation; for example, the
activation of various ECM and cytoskeletal proteins to
remodel the cell architecture. It is possible that such a
model can be used to investigate the roles of Wnts, and
how they transduce their signals, in other systems.
Methods
Cell culture, reagents and retroviral infection
Information with respect to cell culture techniques and
reagents can be found in [33,34,39].
RNA isolation and Northern blot analysis
Total RNA was isolated from cells at high degrees of con-
fluency (≥95%) and Northern blot analyses were carried
out as described [39].
Suppression Subtractive Hybridization (SSH)
SSH was performed using the PCR-Select cDNA Subtrac-
tion Kit (CLONTECH). Tester double-stranded cDNA was
synthesized from 2 µg poly(A+) RNA that was isolated
from the C57MG/Wnt-1 cell line. Driver double-stranded
cDNA was isolated from 2 µg poly(A+) RNA from the
C57MG parent cell line. After the subtractive hybridiza-
tion, the subtracted cDNA was subcloned into the pGEM-
T vector for further analysis. For additional information
with respect to SSH, please see [33,72-74].
Differential screening (dot blotting)
Five (5) µg of DNA of each of the putative Wnt-1 respon-
sive clones were spotted onto nitrocellulose membranes
and baked for two hours at 80°C under vacuum. Poly(A+)
RNA was prepared from either C57MG cells infected with
Wnt-1 or the empty vector retrovirus, C57MG cells stably
expressing a the T41A, S45A stable mutant form of β-cat-
enin (4145 β-catenin), or C57MG cells co-cultured with
QT6 or QT6Wnt-1 cells. 2 µg of poly(A+) RNA was con-
verted to labeled cDNA in the presence of oligo(dT), ran-
dom hexamers, unlabeled ATP, CTP, GTP, UTP, reverse
transcriptase, and [32P]CTP. Prehybridization, hybridiza-
tion, and washing procedures were followed as per the
Northern blot procedure described previously [39]. The
membranes were exposed to a STORM PhosphorImager
(Molecular Dynamics/Amersham Pharmacia Biotech)
and quantitated using the ImageQuant program (Molecu-
lar Dynamics/Amersham Pharmacia Biotech) based on
the ratio of each signal in the Wnt-1-treated cells to the
signal in the control-treated cells (each normalized to
GAPDH).
Semi-quantitative reverse transcription-polymerase chain 
reaction (QRT-PCR)
QRT-PCR was performed using varying amounts of total
RNA in accordance with the TaqMan protocol (Applied
Biosystems).
Labeled immunoprecipitation
Immunoprecipitation was performed as previously
described in [39].
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